• Best Practices New Normal
  • Digital Dentistry
  • Data Security
  • Implants
  • Catapult Education
  • COVID-19
  • Digital Imaging
  • Laser Dentistry
  • Restorative Dentistry
  • Cosmetic Dentistry
  • Periodontics
  • Oral Care
  • Evaluating Dental Materials
  • Cement and Adhesives
  • Equipment & Supplies
  • Ergonomics
  • Products
  • Dentures
  • Infection Control
  • Orthodontics
  • Technology
  • Techniques
  • Materials
  • Emerging Research
  • Pediatric Dentistry
  • Endodontics
  • Oral-Systemic Health

New Report Shows Dentists in Good Compliance with AHA Guidelines

News
Article

The American Heart Association put out guidelines in 2007 regarding use of prophylactics prior to dental procedures. A recent study from the Rochester Epidemiology Project has found that since the implementation of the guidelines, dental surgeons have remained compliant. Continue below to learn more about the AHA's efforts to reduce needless antibiotic use.

Before the ADA's guidelines, prophylactic antibiotics were recommended for all patients with an increased risk of infective endocarditis.

In the first study of its kind, researchers have examined dental records included in the Rochester Epidemiology Project and found that dentists and oral surgeons are in compliance with guidelines put forth by the American Heart Association (AHA) in 2007. These guidelines were intended to direct the use of prophylactic antibiotics administered before invasive dental surgeries and other procedures.

RELATED: More Coverage on

  • CDA Launches the Dentists Service Company to Support Members
  • Done Right, Cosmetic Dentistry Offers Financial Rewards
  • How to Become a Better Investor by Counteracting Bias

Before the new guidelines were issued in 2007, the AHA recommended prophylactic antibiotics for all patients with cardiac conditions that put them at a higher risk of developing infective endocarditis, a serious and potentially deadly infection of the heart valves. However, it was determined that this group of patients actually represented a small percentage of people receiving antibiotics prior to dental procedures. As a result, the AHA updated their guidelines to reflect this new data. After the guidelines were updated, there was no significant increase in cases of infective endocarditis recorded.

“Using the Rochester Epidemiology Project, we have shown that the new guidelines were very helpful in reducing unnecessary antibiotic use and related issues, without an increase in new cases of infective endocarditis,” Daniel DeSimone, M.D. and study lead authors, says.

The research highlights other problems potentially avoided when patients are not given unnecessary antibiotics.

“Overuse of antibiotics can result in increased bacterial resistance, which is a widespread public health problem,” says DeSimone. Additionally, the estimated cost of antibiotics prescribed to moderate-risk cardiac patients could total over $100 million each year.

While this is the first study to use dental records included in the Rochester Epidemiology Project, there have already been over 2,600 medical publications already presented. The Project features a medical record linkage system that includes data from more than 500,000 patients over the last 50 years. This data allows scientists to examine the causes of many diseases and how patients respond to treatments, including surgery, medication or other alternative interventions while forecasting possible patient outcomes as a result of these interventions.

Discover more Dentist’s Money Digest® news here.

Related Videos
2024 Dental Products Report Spring Selection Bracket Reveal Video
Process of Care Workflow and Repairing Early Caries with Guided Enamel Remineralization
Addressing Unmet Needs in Early Childhood Oral Care - an interview with Ashlet Lerman, DDS
Mastermind Episode 33 – Charting the Course for the Future of Dentistry
CDS 2024 Midwinter Meeting – Interview with Debbie Zafiropoulos, who discusses a trio of new infection control products from Armis Biopharma.
2024 Chicago Dental Society Midwinter Meeting – Interview with Peter Maroon, business development and sales lead at Spectrum Solutions® on the new salivary diagnostic test, SimplyPERIO.
CDS 2024: Ivoclar's e.max ZirCAD Prime Blocks with Shashi Singhal, BDS, MS
CDS 2024: Diving Deep on J. Morita's New Root ZX3 & HF Module
CDS 2024: What's New at TAG University? with Andrew De la Rosa, DMD
Related Content
© 2024 MJH Life Sciences

All rights reserved.